WASHINGTON, D.C. — CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement in response to results from a recent trial published in the American Journal of Clinical Nutrition (AJCN), finding that adults ages 60 and older who took a daily multivitamin (MVM) showed a “significantly more favorable change in episodic memory,” reducing cognitive aging by two years compared to those who took the placebo. These results mark the third time a MVM clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) has confirmed the positive benefits MVM’s have on older adults’ cognitive health.
“Even individuals with the healthiest diets often fail to reach the recommended daily intake level for vitamins and nutrients. As we age, achieving this goal becomes even more important to protect memory and brain function. With an urgent need to identify strategies to preserve memory and thinking abilities in older adults and reduce the burden of cognitive decline on families and society, these results are certainly important, as they show how supplements can support certain aging adults in meeting their daily nutrient needs for better cognitive function – a critical part of healthy aging for the mind and body.
“While there is no proven prevention or treatment for cognitive decline, scientific evidence grows in increments, and seeing positive results emerge from this study once again reinforces the beneficial role safe, accessible, and affordable vitamins and supplements can play in optimizing health through responsible self-care.”